The drug-eluting balloon catheter is an advanced medical device that has shown remarkable efficiency in carrying out various peripheral artery and cardiovascular procedures. A large number of companies are now shifting towards the manufacturing of drug-eluting balloon catheters as they are proving to be more efficient as compared to stenting or balloon angioplasty.
In addition, drug-eluting balloon catheters can also help in treating patients who do not benefit from percutaneous coronary intervention (PCI). Factors as such are expected to favor the global drug-eluting balloon catheter market in the near future.
An increasing number of patients with cardiovascular ailments and the surging rate of cardiology intervention procedures are driving the demand for drug-eluting balloon catheters. Drug-eluting balloon catheters manufacturers are also trying to develop low-cost devices, which will further boost its adoption over the next couple of years.
As per the latest report published by Fact.MR, the global drug-eluting balloon catheter market is poised to grow to reflect a staggering CAGR of 18.3% during the forecast period 2018 and 2022. At the same time, improved reimbursement support, increasing healthcare expenditure, and a growing geriatric population are some of the other additional factors likely to influence the growth of the market.
Drug-eluting balloon (DEB), also known as drug-coated balloon (DCB) is one of the newest medical devices under the catheter segment. The drug-eluting balloon catheter is used in undertaking peripheral artery procedures, particularly to reduce the rate of restenosis. A drug-eluting balloon catheter is inserted into a narrowed, unhealthy coronary or peripheral artery that slowly releases a drug to restrict further cell proliferation.
Drug Eluting Balloon Catheter Market in Europe to Remain Highly Attractive
Europe is currently the largest market for drug eluting balloon catheter and is expected to continue its dominance throughout the assessment period. The market in the region is set to reflect a robust CAGR of 20.5% during the assessment period. Meanwhile, the market in Asia-Pacific excluding Japan (APEJ) will reflect the fastest CAGR and gain 452 BPS between 2017 and 2022.
By indication, the coronary artery disease will continue to hold its dominant position over 2022. The segment currently accounts for around 83% share of the market in terms of value. Towards the end of the forecast period, this segment is expected to surpass a market valuation of US$ 378 Mn in 2022, reflecting a robust CAGR.
By end user, the hospital segment is expected to retain its predominant position over the assessment period. In terms of revenue, the segment accounts for around 73% share of the market. By 2022-end, the hospital segment is expected to reach a market valuation of over US$ 333 Mn.
Know More Details About the Report
- Cardionovum GmbH
- Cook Medical INC
- Cordis Corporation
- Abbott Laboratories
- Meril Life Sciences Pvt Ltd
- Jotech GmbH
- MicroPort Scientific Corporation
- Terumo Corporation
- Boston Scientific Corporation
- Tokai Medical Products Inc.
- BIOTRONIK SE & Co. KG
- B. Braun Melsungen AG
- Medtronic Plc.
are the leading companies profiled in Fact.MR’s report.
(Additional information, including cross-sectional data and country-wise analysis & forecast is available in the report)
Considering the widespread prevalence of vascular ailment, companies are emphasizing on developing low-cost and more efficient catheter technology. This Fact.MR report analyzes the expansion of the global drug-eluting balloon catheter market till date and provides key insights on the growth of the market during the forecast period, 2017-2022.
The scope of Fact.MR’s report is to analyze the global drug-eluting balloon catheter market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global drug-eluting balloon catheter market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to medical devices.
The report commences with brief information of the global drug-eluting balloon catheter market. This executive summary sets the tone for the rest of the report, providing users the scope of the report. The executive summary includes important facts and statistics on the global drug-eluting balloon catheter market.
The next section offers an overview of the global drug-eluting balloon catheter market. This comprises an introduction to the market, along with a standard definition of the product – drug eluting balloon catheter. In this section, market value and year-over-year growth is offered to the readers. Year-over-year growth provides readers with a broader view of growth patterns over the forecast period.
The report’s succeeding section focuses on drivers, restraints, and key trends from macroeconomic, demand, and supply perspectives. Impact analysis of weighted average model-based growth drivers is contained in the report for better provision of decision-making insights to clients.
In order to offer readers with up-to-date information about the latest advancements in the global drug-eluting balloon catheter market, the report provides updates about market opportunities, which can benefit leading manufacturers of drug eluting balloon catheters. With the continuous evolution of the healthcare sector, keeping a record of latest developments and trends is fundamental for drug eluting balloon catheter manufacturers to formulate key business strategies. Detailed insights about raw material sourcing, supply chain, regulatory approvals, pricing analysis, list of distributors, and cost structure are provided in this section.
The Fact.MR report provides segment-wise analysis and forecast for covering the wide scope of the global drug-eluting balloon catheter market. Indication, end user, raw material and region are key segments that define the growth of the global market for drug eluting balloon catheter. In this segmentation analysis, a detailed country-wise forecast across all key market parameters is also included.
The report’s last section comprises of the global drug eluting balloon catheter market competitive landscape, to provide readers with the dashboard view of company analysis and market players. This competitive intelligence is based on the providers’ categories across value chain, and their presence in the global drug eluting balloon catheter market.
Fact.MR is committed to offer unbiased and independent market research solutions to its clients. Each market report of Fact.MR is compiled after months of exhaustive research. We bank on a mix of tried-and-tested and innovative research methodologies to offer the most comprehensive and accurate information. Our main sources of research include,
- Primary research
- Secondary research
- Trade research
- Focused interviews
- Social media analysis
Need an Exclusive Report for your Unique Requirement?
- Related Reports -
- Our Clients -
- Evaluate How Fact.MR's Report Can Help. -
Is the market research conducted by Fact.MR?
Yes, the report has been compiled by expert analysts of Fact.MR, through a combination of primary and secondary research. To know more about how the research was conducted, you can speak to a research analyst.
What research methodology is followed by Fact.MR?
Fact.MR follows a methodology that encompasses the demand-side assessment of the market, and triangulates the same through a supply-side analysis. This methodology is based on the use of standard market structure, methods, and definitions.
What are the sources of secondary research?
Fact.MR conducts extensive secondary research through proprietary databases, paid databases, and information available in the public domain. We refer to industry associations, company press releases, annual reports, investor presentations, and research papers. More information about desk research is available upon request.
Who are the respondents for primary research?
Fact.MR speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, and industry experts. For a full list of primary respondents, please reach out to us.
Is a sample of this report available for evaluation?
Yes, you can request a sample, and it will be sent to you through an email.